ArticlePeerJ2024

Retraction: Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway.

PeerJ Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.